Drugs / Adipose-derived stem cells without expanded
Adipose-derived stem cells without expanded
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01548092 | Dec 2011 → Jul 2012 | intestinal fistula | Instituto de Investigación Hospital Universitario La Paz | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adipose-derived stem cells without expanded | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01548092 ↗ |
| Modality | Cell therapy | “Adipose-derived stem cells without expanded” NCT01548092 ↗ |
| Route | Other | “Administration will be intralesional injection of cells suspension.” NCT01548092 ↗ |